Evidence map›Paper›PMID 37687895›Full record

ArticleSensors (Basel, Switzerland)2023

Introducing a New Mobile Electroencephalography System and Evaluating Its Quality in Comparison to Clinical Electroencephalography.

Paria Samimisabet, Laura Krieger, Themis Nethar, Gordon Pipa

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paria SamimisabetInstitute of Cognitive Science, Osnabrueck University, 49074 Osnabrück, Germany.
Laura KriegerInstitute of Cognitive Science, Osnabrueck University, 49074 Osnabrück, Germany.
Themis NetharInstitute of Cognitive Science, Osnabrueck University, 49074 Osnabrück, Germany.
Gordon PipaInstitute of Cognitive Science, Osnabrueck University, 49074 Osnabrück, Germany.

Funding

Bundesministerium für Bildung und Forschung FKZ 16DHB2123
6 · The paper itself

Abstract

Electroencephalography (EEG) is a crucial tool in cognitive neuroscience, enabling the study of neurophysiological function by measuring the brain's electrical activity. Its applications include perception, learning, memory, language, decision making and neural network mapping. Recently, interest has surged in extending EEG measurements to domestic environments. However, the high costs associated with traditional laboratory EEG systems have hindered accessibility for many individuals and researchers in education, research, and medicine. To tackle this, a mobile-EEG device named "DreamMachine" was developed. A more affordable alternative to both lab-based EEG systems and existing mobile-EEG devices. This system boasts 24 channels, 24-bit resolution, up to 6 h of battery life, portability, and a low price. Our open-source and open-hardware approach empowers cognitive neuroscience, especially in education, learning, and research, opening doors to more accessibility. This paper introduces the DreamMachine's design and compares it with the lab-based EEG system "asalabTM" in an eyes-open and eyes-closed experiment. The Alpha band exhibited higher power in the power spectrum during eyes-closed conditions, whereas the eyes-open condition showed increased power specifically within the Delta frequency range. Our analysis confirms that the DreamMachine accurately records brain activity, meeting the necessary standards when compared to the asalabTM system.

Indexed as

Computers, HandheldLearningElectric Power SuppliesElectroencephalographyEyeHumansBluetoothelectroencephalogram (EEG)eyes open/closedmobile EEGresting state

Identifiers

PMID37687895
PMCPMC10490595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.